The Truly Staggering Cost Of Inventing New Drugs

During the Super Bowl, a representative of the pharmaceutical company Eli Lilly posted the on the company’s corporate blog that the average cost of bringing a new drug to market is $1.3 billion, a price that would buy 371 Super Bowl ads, 16 million official NFL footballs, two pro football stadiums, pay of almost all NFL football players, and every seat in every NFL stadium for six weeks in a row. This is, of course, ludicrous. The average drug developed by a major pharmaceutical company costs between $4-$11 billion. [read more]

The Truly Staggering Cost Of Inventing New Drugs2022-09-22T15:15:59+00:00

Review on Antimicrobial Resistance

The Review on Antimicrobial Resistance (AMR), was commissioned in July 2014 by the UK Prime Minister, who asked economist Jim O’Neill to analyse the global problem of rising drug resistance and propose concrete actions to tackle it internationally. The Review on AMR was jointly supported by the UK Government and Wellcome Trust, although operated with full independence from both. The final report and recommendations were published in the summer of 2016. [read more]

Review on Antimicrobial Resistance2022-09-22T15:33:28+00:00

Innovative Ways to Pay for New Antibiotics Will Help Fight Superbugs

Antibiotics are the most important drug class in human history. Without them, minor infections could turn deadly. Heart surgery, cancer treatment, and virtually everything else that happens in a hospital would be far more dangerous than it is today. But if we keep taking them for granted, and fail to provide innovative approaches to funding the development of new antibiotics, drug-resistant microbes will get the upper hand. [read more]

Innovative Ways to Pay for New Antibiotics Will Help Fight Superbugs2022-09-22T15:34:53+00:00

Superbugs: An Arms Race against Bacteria

Unnecessary use of antibiotics in both humans and animals accelerates the evolution of drug-resistant bacteria, with potentially catastrophic consequences. Our best defenses against infectious disease could cease to work, surgical procedures would become deadly, and we might again find small cuts to be life-threatening. The problem of drug resistance already kills over one million people across the world every year and has huge economic costs. Without action, this problem will become significantly worse. [read more]

Superbugs: An Arms Race against Bacteria2022-09-22T15:39:01+00:00

High Levels Of Antibiotic Resistance Found Worldwide

WHO's new Global Antimicrobial Surveillance System reveals widespread occurrence of antibiotic resistance among 500,000 people with suspected bacterial infections across 22 countries. The most commonly reported resistant bacteria were Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, and Streptococcus pneumoniae, followed by Salmonella spp. Among patients with suspected bloodstream infection, the proportion that had bacteria resistant to at least one of the most commonly used antibiotics ranged tremendously between different countries – from zero to 82%. [read more]

High Levels Of Antibiotic Resistance Found Worldwide2022-09-22T17:04:20+00:00
Go to Top